UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective

Journal of clinical oncology, 2015-10, Vol.33 (29), p.3356-3364

2015

Volltextzugriff (PDF)

Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinoma

Oral oncology, 2021-02, Vol.113, p.105127-105127, Article 105127

2021

Volltextzugriff (PDF)

Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer

The New England journal of medicine, 2017-08, Vol.377 (6), p.513-522

2017

Volltextzugriff (PDF)

Immunotherapy for Head and Neck Cancer

1, 2023

Volltextzugriff (PDF)

Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin

Genome research, 2019-03, Vol.29 (3), p.418-427

2019

Volltextzugriff (PDF)

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial

Journal of clinical oncology, 2018-11, Vol.36 (31), p.JCO2018777847-3100

2018

Volltextzugriff (PDF)

Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials

Clinical cancer research, 2018-04, Vol.24 (8), p.1824-1833

2018

Volltextzugriff (PDF)

Personalizing Therapy for Colorectal Cancer

Clinical gastroenterology and hepatology, 2014, Vol.12 (1), p.139-144

2014

Volltextzugriff (PDF)

The emerging data on choice of optimal therapy for locally advanced nasopharyngeal carcinoma

Current opinion in oncology, 2020-05, Vol.32 (3), p.187-195

2020

Volltextzugriff (PDF)

Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein―Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients

Cancer research (Chicago, Ill.), 2013-03, Vol.73 (6), p.1676-1688

2013

Volltextzugriff (PDF)

New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy

Journal of clinical oncology, 2009-01, Vol.27 (3), p.446-452

2009

Volltextzugriff (PDF)

Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma

Radiotherapy and oncology, 2012-09, Vol.104 (3), p.300-304

2012

Volltextzugriff (PDF)

Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma models

Investigational new drugs, 2023-10, Vol.41 (5), p.699-709

2023

Volltextzugriff (PDF)

MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target

Theranostics, 2022-01, Vol.12 (15), p.6509-6526

2022

Volltextzugriff (PDF)

Sequencing Analysis of Plasma Epstein-Barr Virus DNA Reveals Nasopharyngeal Carcinoma-Associated Single Nucleotide Variant Profiles

Clinical chemistry (Baltimore, Md.), 2020-04, Vol.66 (4), p.598-605

2020

Volltextzugriff (PDF)

Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: Current and future directions

Cancer science, 2008-07, Vol.99 (7), p.1311-1318

2008

Volltextzugriff (PDF)

Predictive factors for overall quality of life in patients with advanced cancer

Supportive care in cancer, 2013-06, Vol.21 (6), p.1709-1716

2013

Volltextzugriff (PDF)

Multicenter, Phase II Study of Cetuximab in Combination With Carboplatin in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Journal of clinical oncology, 2005-05, Vol.23 (15), p.3568-3576

2005

Volltextzugriff (PDF)

Colorectal cancer in Chinese patients: current and emerging treatment options

OncoTargets and therapy, 2014-01, Vol.7, p.1817-1828

2014

Volltextzugriff (PDF)

Preclinical evaluation of the mTOR–PI3K inhibitor BEZ235 in nasopharyngeal cancer models

Cancer letters, 2014-02, Vol.343 (1), p.24-32

2014

Volltextzugriff (PDF)

The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines

Investigational new drugs, 2010-04, Vol.28 (2), p.107-114

2010

Volltextzugriff (PDF)

Combined-Modality Treatment of Solid Tumors Using Radiotherapy and Molecular Targeted Agents

Journal of clinical oncology, 2003-07, Vol.21 (14), p.2760-2776

2003

Volltextzugriff (PDF)

Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network

Supportive care in cancer, 2011-10, Vol.19 (10), p.1625-1635

2011

Volltextzugriff (PDF)

Genome-wide expression analysis using microarray identified complex signaling pathways modulated by hypoxia in nasopharyngeal carcinoma

Cancer letters, 2007-08, Vol.253 (1), p.74-88

2007

Volltextzugriff (PDF)

Plasma Osteopontin, Hypoxia, and Response to Radiotherapy in Nasopharyngeal Cancer

Clinical cancer research, 2008-11, Vol.14 (21), p.7080-7087

2008

Volltextzugriff (PDF)

1 – 25 von 117

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(105)

Publikationsform

Sprache

Englisch
(117)

Erscheinungsjahr

n.n

Thema

Science & Technology
(93)
Life Sciences & Biomedicine
(88)
Humans
(72)
Oncology
(69)
Nasopharyngeal Carcinoma
(39)
Female
(37)
Male
(36)
Adult
(30)
Middle Aged
(29)
Tumors
(29)
Biological And Medical Sciences
(24)
Cancer
(23)
Medical Sciences
(23)
Aged
(22)
Nasopharyngeal Neoplasms - Pathology
(22)
Epstein-Barr Virus
(19)
Medicine
(18)
Medicine & Public Health
(17)
Cell Line, Tumor
(16)
Nasopharyngeal Neoplasms - Drug Therapy
(16)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective

Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinoma

Analysis of Plasma Epstein–Barr Virus DNA to Screen for Nasopharyngeal Cancer

Immunotherapy for Head and Neck Cancer

Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial

Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized Trials

Personalizing Therapy for Colorectal Cancer

The emerging data on choice of optimal therapy for locally advanced nasopharyngeal carcinoma

Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein―Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients

New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy

Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma

Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma models

MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target

Sequencing Analysis of Plasma Epstein-Barr Virus DNA Reveals Nasopharyngeal Carcinoma-Associated Single Nucleotide Variant Profiles

Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: Current and future directions

Predictive factors for overall quality of life in patients with advanced cancer

Multicenter, Phase II Study of Cetuximab in Combination With Carboplatin in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Colorectal cancer in Chinese patients: current and emerging treatment options

Preclinical evaluation of the mTOR–PI3K inhibitor BEZ235 in nasopharyngeal cancer models

The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines

Combined-Modality Treatment of Solid Tumors Using Radiotherapy and Molecular Targeted Agents

Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network

Genome-wide expression analysis using microarray identified complex signaling pathways modulated by hypoxia in nasopharyngeal carcinoma

Plasma Osteopontin, Hypoxia, and Response to Radiotherapy in Nasopharyngeal Cancer

Suchergebnisse filtern